2016
DOI: 10.1177/1756283x16642190 View full text |Buy / Rent full text
|
|

Abstract: Inflammatory bowel disease (IBD) is a chronic, often relapsing, condition that deeply impacts the quality of life for many patients. Although there have been significant advances in medical treatments, a large proportion of patients become refractory to available therapeutic options. Stem-cell therapy through hematopoietic stem cells (HSCs) or mesenchymal stem (stromal) cells (MSCs) is a promising therapeutic option for severe refractory cases especially when surgery is not feasible. In HSC transplantation, th… Show more

Help me understand this report

Search citation statements

Order By: Relevance
Select...
0
19
0

Publication Types

Select...

Relationship

0
0

Authors

Journals